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Modified Pulmonary Index Score Was
Sufficiently Reliable to Assess the
Severity of Acute Asthma
Exacerbations in Children
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Yukihiro Ohya4 and Hidefumi Nakamura5
ABSTRACT
Background: The Modified Pulmonary Index Score (MPIS) was developed as an indicator of the severity of
acute asthma in children. The objective of this study is to evaluate the reliability and validity of the MPIS for chil-
dren with acute asthma, including those five years or younger in age.
Methods: We evaluated the inter-rater reliability and internal consistency of the MPIS by having at least two
trained physicians and a nurse―each of whom was blinded to the others’ scores―simultaneously examine in-
patients with asthma exacerbation and rate them according to the MPIS. We also evaluated the intraclass cor-
relation coefficient (ICC), kappa, Cronbach’s α and correlations between the MPIS and other indicators associ-
ated with asthma severity.
Results: A total of 25 children (median age, five years; 13 patients were five years or younger in age) were en-
rolled in this study. The MPIS showed excellent inter-rater reliability (all ages: ICC = 0.95, 95% CI = 0.94-0.97;
five years or younger: ICC = 0.93, 95% CI = 0.89-0.96) and good internal consistency (all ages: Cronbach’s α =
0.87; five years or younger: Cronbach’s α = 0.85). The MPIS showed good correlation with a visual analogue
scale assessed by the physicians.
Conclusions: The MPIS was a sufficiently reliable assessment tool for children with acute asthma, including
those five years or younger in age.
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INTRODUCTION
Bronchial asthma is one of the most common chronic
childhood disorders in the world. More than 90,000
of such patients younger than 18 years old require
hospitalization annually in Japan, with a majority of
them being preschool children. Appropriate objective
assessment for acute asthma severity is essential, not
only for evaluating the effectiveness of treatment, but
also for sharing patient information among medical
professionals. Although pulmonary function tests are
commonly used to assess the severity of acute
asthma in adults, they are difficult to perform in chil-
dren, especially those who are younger than five
years old.1
Accordingly, several clinical scores have been de-
veloped in order to evaluate the severity of asthma at-
tacks.2-8 Carroll et al.9 developed and evaluated the
Modified Pulmonary Index Score (MPIS) in 2005
based on data obtained from 30 children with a mean
age of 7.6 years. They reported high inter-rater repro-
ducibility and good correlations of the MPIS with
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Table　1　The Modifi ed Pulmonary Index Score (MPIS)
Score
0 1 2 3
Oxygen saturation, % >95 93-95 90-92 <90
Accessory muscle use None Mild Moderate Severe
Inspiratory-to-expiratory fl ow ratio 2 : 1 1 : 1 1 : 2 1 : 3
Wheezing None Endexpiratory
Inspiratory and expiratory
wheeze, good aeration
Inspiratory and expiratory
wheeze, decreased aeration
Heart rate <3 years old <120 120-140 141-160 >160
≥3 years old <100 100-120 121-140 >140
Respiratory rate <6 years old ≤30 31-45 46-60 >60
≥6 years old ≤20 21-45 36-50 >50
clinical outcomes such as ICU admission. The MPIS
appears to be suitable for measuring the severity of
acute asthma exacerbation, and was applied as pri-
mary outcome measurement in some clinical tri-
als.10,11 However, its applicability to preschool chil-
dren has not yet been fully elucidated. In this study,
we evaluated the inter-rater reliability and internal
consistency of the MPIS in a younger population, in-
cluding preschool children.
METHODS
This study was approved by the Institutional Ethics
Review Board, and informed consent was obtained
before enrollment. Between September 2009 and
February 2011, patients who were admitted to the
hospital with asthma exacerbation were considered
for enrollment in the study. Patients were eligible if
they were one to 12 years of age and had previously
been diagnosed with asthma. Patients were excluded
if (1) acute conditions such as croup or pneumonia
were present, (2) asthma exacerbation was severe
enough to require ventilatory support, (3) altered
mental status was observed, or (4) there were under-
lying pulmonary or cardiac conditions.
The MPIS consisted of six items: (1) oxygen satu-
ration on room air (SpO2), (2) accessory muscle use,
(3) inspiratory-to-expiratory flow ratio (I:E ratio), (4)
degree of wheezing, (5) heart rate (HR) and (6) respi-
ratory rate (RR). For each of these items, a score of 0
to 3 is assigned based on the severity. The range of
total score is 0 to 18. The higher the total score is, the
more severe the condition (Table 1).
RATERS AND THEIR TRAINING
Forty-five physicians (three pediatric allergists, six
pediatric hospitalists and 36 residents) and 12 nurses
(all of whom were pediatric ward nurses) participated
in this study as raters of the MPIS.
Before starting this study, we developed digital
learning software for the MPIS that contained re-
corded auscultation sounds, video images and com-
puter graphics of the asthma exacerbation with vary-
ing severity. This software was developed to stan-
dardize evaluation of the subjective MPIS items, i.e.,
(2) through (4), described above. All of the raters
completed training with this software and evaluated
their skills with 10 test cases after training.
ASSESSMENT OF THE PATIENTS
To evaluate the inter-rater reliability of the MPIS, at
least two physicians and a nurse―each of whom was
blinded to the other raters’ scores―simultaneously
assessed each inpatient’s asthma using the MPIS. Pa-
tients were assessed at admission and at one or two
more times subsequently, with an interval of at least
eight hours.
In addition to the assessment with MPIS, physi-
cians were required to score their subjective evalu-
ation of the severity of asthma exacerbation with a
Visual Analogue Scale (VAS) from 0 (no symptoms)
to 10 (needs intubation). At the same time, with
raters’ evaluation, the parents were asked to score
the degree of dyspnea of their child using a 10-point
scale, with 10 representing the status at admission.
STATISTICAL ANALYSIS
The inter-rater reliability of the total MPIS was evalu-
ated using the intraclass correlation coefficient (ICC).
The inter-rater reliability of each item was evaluated
using a weighted kappa coefficient for two evalu-
ations: two physicians, and a physician and a nurse.
Some raters evaluated the same patient sequentially,
followed by the ICC of the reduction of MPIS within-
rater and within-patient being calculated.
The internal consistency was evaluated as Cron-
bach’s alpha coefficient. The correlation of the MPIS
and the physicians’ VAS was assessed by Pearson’s
correlation coefficients to explore the concurrent va-
lidity. Responsiveness was evaluated using Pearson’s
correlation coefficients of the reduction of average
MPIS and that of VAS and the parents’ evaluation. All
analyses were performed for all ages group, five
years or younger (younger-age group), and six years
or older. Data were analyzed with SAS software ver-
Modified Pulmonary Index Score
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Table　2　Characteristics at admission
Patients (N = 25)
Age [median (range)] 5.0 (2-12)
1-5 years old [N (%)] 13 (52.0)
6-12 years old [N (%)] 12 (48.0)
MPIS at entry [median (range)] 10 (5-16)
Simultaneous evaluation (62 times) Frequency (%)
Age
1-5 years old 31 (50.0)
6-12 years old 31 (50.0)
Consciousness
Sleep 3 (4.8)
Awake 59 (95.2)
Posture
Sitting 42 (67.7)
Lying 20 (32.3)
Crying
Yes 2 (3.2)
No 60 (96.8)
Physician’s assessment of asthma 
exacerbation severity
Mild 25 (40.3)
Moderate 25 (40.3)
Severe 12 (19.3)
Respiratory arrest imminent 0
Table　3　Inter-rater reliability of MPIS
All ages 1-5 years 6-12 years
ICC of overall MPIS 0.95 (0.94-0.97) 0.93 (0.89-0.96) 0.97 (0.95-0.98)
Kappa coefficients between two physicians (95% confi dence intervals)
Oxygen saturation in room air 0.96 (0.91-1.00) 1.00 (1.00-1.00) 0.92 (0.82-1.00)
Accessory muscle use 0.84 (0.76-0.92) 0.88 (0.78-0.98) 0.80 (0.68-0.93)
I:E ratio 0.69 (0.57-0.82) 0.50 (0.28-0.73) 0.77 (0.62-0.92)
Degree of wheezing 0.77 (0.63-0.91) 0.76 (0.54-0.97) 0.77 (0.57-0.96)
Heart rate 0.96 (0.93-1.00) 0.93 (0.86-1.00) 0.99 (0.96-1.00)
Respiratory rate 0.85 (0.75-0.95) 0.80 (0.65-0.96) 0.88 (0.75-1.00)
Kappa coefficients between physician and nurse (95% confi dence intervals)
Oxygen saturation in room air 1.00 (1.00-1.00) 1.00 (1.00-1.00) 1.00 (1.00-1.00)
Accessory muscle use 0.77 (0.63-0.92) 0.78 (0.61-0.95) 0.67 (0.40-0.93)
I:E ratio 0.61 (0.40-0.82) 0.56 (0.32-0.80) 0.80 (0.41-1.00)
Degree of wheezing 0.77 (0.55-0.99) 0.69 (0.42-0.97) 0.75 (0.36-1.00)
Heart rate 0.92 (0.84-1.00) 0.90 (0.80-1.00) 1.00 (1.00-1.00)
Respiratory rate 0.74 (0.51-0.97) 0.54 (0.29-0.79) 0.88 (0.69-1.00)
ICC, Intraclass Correlation Coefficient.
sion 9.1 (SAS Institute, Cary, NC, USA).
RESULTS
A total of 62 simultaneous assessments for 25 patients
were performed. Table 2 summarizes the admission
characteristics and clinical condition of the partici-
pants.
INTER-RATER RELIABILITY
Table 3 shows the ICC of the overall MPIS and the
kappa coefficients for each item score. The ICC was
excellent for both the all-ages group (ICC = 0.95, 95%
CI = 0.94-0.97) and the younger-age group (ICC =
0.93, 95% CI = 0.89-0.96). Kappa coefficients for each
item were also high, especially for the objective items
(oxygen saturation, RR and HR) and accessory mus-
cle use. The overall MPIS scores were plotted in Fig-
ure 1 [(a) between physicians, and (b) between one
physician and one nurse]. Both plots showed a posi-
tive linear trend. Pearson’s correlation coefficients
were R = 0.96 (95% CI = 0.93-0.97) between two physi-
cians and R = 0.95 (95% CI = 0.90-0.98) between one
physician and one nurse. The ICC of the MPIS reduc-
tion was also preferable (ICC = 0.75, 95% CI = 0.66-
0.84) for the all-age group.
INTERNAL CONSISTENCY, CONCURRENT VA-
LIDITY AND RESPONSIVENESS
With regard to construct validity, the internal consis-
tency of the MPIS was good for the total patients
(Cronbach’s alpha = 0.87), and was the same for the
patients of each younger and older age group (Cron-
bach’s alpha = 0.85 and 0.89, respectively). Each of
the six components contributed significantly to the
overall MPIS (Table 4). With regard to concurrent va-
lidity, Pearson’s correlation coefficients between the
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Fig.　1　(a) Scatter plots of the scores evaluated simultane-
ously between two physicians and (b) between a physician 
and a nurse. White diamonds denote children aged 1-5 
years, while black dots denote children aged 6-12 years.
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Table　4　Internal consistency of MPIS
All 
ages
1-5 
years
6-12 
years
Cronbach’s coefficient alpha 0.87 0.85 0.89
Cronbach’s coefficient alpha with deletion of each item
Oxygen saturation in room air 0.86 0.85 0.87
Accessory muscle use 0.82 0.80 0.85
I:E ratio 0.86 0.84 0.88
Degree of wheezing 0.85 0.82 0.87
Heart rate 0.85 0.82 0.86
Respiratory rate 0.86 0.83 0.88
MPIS and the physicians’ mean VAS were 0.92 (0.86-
0.95) in the total patients and 0.91 (0.81-0.96) in the
five-year-old and younger patients.
As for responsiveness, Pearson’s correlation coeffi-
cient for the reduction in the MPIS relative to reduc-
tion in the VAS was 0.85 (0.65-0.93) in the total popu-
lation, and 0.86 (0.58-0.97) in the five-year-old and
younger patients. The coefficient for correlation be-
tween the reduction in the MPIS relative to the reduc-
tion in the parents’ evaluated score from the 10 points
at admission was 0.76 (0.47-0.89, N = 21) in the total
population, and 0.69 (0.07-0.91, N = 10) in the
younger-age group.
DISCUSSION
Carroll et al.9 reported the predictive validity and re-
producibility of the MPIS for asthma exacerbations in
30 children with a mean age of 7.6 ± 5.5 years in 2005.
Its applicability for preschool children, however, was
not clearly demonstrated. This study was designed to
evaluate the inter-rater reliability and internal consis-
tency of the MPIS when used for pediatric popula-
tions including those younger than five years old.
Overall, 13 of the 25 recruited children were five
years old or younger, and 31 of 62 simultaneous as-
sessments were performed for this age group.
Our simultaneous assessments were performed
with the raters blinded to each other, and data were
analyzed by an independent data manager and statis-
tician. These procedures aimed at eliminating rater
bias and analytical bias.
The overall inter-rater reliability of the MPIS was
excellent between physicians and between a physi-
cian and a nurse; the same was observed for the
younger-age group. Among the six components of
the MPIS, two objective components (oxygen satura-
tion and heart rate) and one subjective component
(the degree of accessory muscle use) showed high
inter-rater reliability. The kappa coefficients for the I:
E ratio for patients aged 1-5 years were relatively low,
indicating that higher respiratory rate in younger
ages may make it difficult to standardize the evalu-
ation of the I:E ratio.
In the absence of a gold standard measure for the
severity of asthma exacerbation in younger children,
we alternatively compared the physicians’ evaluations
of the MPIS with the VAS; strong correlations were
found between them. Although the VAS is subjective,
it is often used as comprehensive clinical assessment.
A good correlation between the MPIS and the VAS
reflects a good face validity of the MPIS.
In this study, the raters were not only those with
clinical expertise, but also nurses and residents un-
der training. Our results support the idea that the
MPIS, combined with proper training for assessment,
can be used widely as a shared assessment tool in
clinical practice, where medical staff with different oc-
Modified Pulmonary Index Score
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cupations or experience often work together and
share patient information.
There were several limitations in this study. First,
the number of assessments was relatively small. Sec-
ond, there was a methodological problem whereby
not all of the 62 simultaneous evaluations were inde-
pendent; 37 of 62 evaluations were performed as sub-
sequent evaluations of 25 initial evaluations. When
the same rater evaluates the same patient at subse-
quent times, the assessment of the subjective compo-
nent can be relative to the previous assessment in-
stead of being an absolute assessment. This could
lead the result in the direction of having a higher de-
gree of correlation. Nonetheless, our results indicate
that the MPIS could be used reliably in a clinical set-
ting where the same physician evaluates the same pa-
tient at several subsequent times.
In summary, the MPIS showed good reliability and
validity for children with acute asthma, including
those five years and younger. The MPIS can serve as
a valuable tool for assessing the severity of asthma
exacerbation in those who are too young or sick to re-
producibly perform pulmonary function tests, or in
settings where such tests are not available.
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